Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update
Hematopoietic cell transplant (HCT) can cure both children and adults with sickle cell disease. Outcomes have historically been poor for the vast majority of patients who lack a matched sibling donor. However, the development of haploidentical HCT (haplo-HCT) with high doses of posttransplant cyclop...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2020-04-01
|
| Serie: | Hematology/Oncology and Stem Cell Therapy |
| Soggetti: | |
| Accesso online: | https://journals.lww.com/10.1016/j.hemonc.2020.01.002 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|